EPISODE · Jul 31, 2024 · 18 MIN
In conversation with... Arndt Vogel
from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet
Arndt Vogel (Toronto General Hospital) discusses the NALIRICC trial of nanoliposomal irinotecan added to fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies.
NOW PLAYING
In conversation with... Arndt Vogel
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m